Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma

Jie Jin,1,2 Rumiko Okamoto,3 Sung-Soo Yoon,4 Lee-Yung Shih,5 Jun Zhu,6 Ting Liu,7 Xiaonan Hong,8 Lixia Pei,9 Brendan Rooney,10 Helgi van de Velde,11 Huiqiang Huang12 1Department of Hematology, The First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, China; 2Key...

Full description

Bibliographic Details
Main Authors: Jin J, Okamoto R, Yoon SS, Shih LY, Zhu J, Liu T, Hong XN, Pei L, Rooney B, van de Velde H, Huang HQ
Format: Article
Language:English
Published: Dove Medical Press 2018-07-01
Series:OncoTargets and Therapy
Subjects:
Mantle cell lymphoma
bortezomib
VR-CAP
R-CHOP
Online Access:https://www.dovepress.com/bortezomib-based-therapy-for-transplant-ineligible-east-asian-patients-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/bortezomib-based-therapy-for-transplant-ineligible-east-asian-patients-peer-reviewed-article-OTT

Similar Items